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Abstract
Exposures to various types of early life stress can be robust predictors of the 
development of psychiatric disorders, including depression and anxiety.  The 
objective of the current study was to investigate the roles of the translationally 
relevant targets of central vasopressin, oxytocin, ghrelin, orexin, glucocorticoid, and 
the brain-derived neurotrophic factor (BDNF) pathway in an early chronic social 
stress (ECSS )based rodent model of postpartum depression and anxiety.  The 
present study reports novel changes in gene expression and extracellular signal 
related kinase (ERK) protein levels in the brains of ECSS exposed rat dams that 
display previously reported depressed maternal care and increased maternal 
anxiety.  Decreases in oxytocin, orexin, and ERK proteins, increases in ghrelin 
receptor, glucocorticoid and mineralocorticoid receptor mRNA levels, and 
bidirectional changes in vasopressin underscore related work on the adverse long-
term effects of early life stress on neural activity and plasticity, maternal behavior, 
responses to stress, and depression and anxiety-related behavior.  The differences 
in gene and protein expression and robust correlations between expression and 
maternal care and anxiety support increased focus on these targets in animal and 
clinical studies of the adverse effects of early life stress, especially those focusing 
on depression and anxiety in mothers and the transgenerational effects of these 
disorders on offspring.
Keywords:  early life stress, depression, anxiety, postpartum depression, 
oxytocin, vasopressin, ghrelin, orexin, mineralocorticoid receptor, 
neuroplasticity.
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Introduction
Exposures to various types of early life stress can be robust predictors of the 
development of psychiatric disorders, including depression and anxiety (Eiland and 
McEwen, 2012; Heim and Binder, 2012; Heim and Nemeroff, 2001; Heim et al., 
1997; Johnson and Sarason, 1978; McEwen, 1998; McEwen, 2003).  Adverse family 
social environments are strongly associated with the development of depression 
(Bouma et al., 2008; Essex et al., 2011; Lizardi et al., 1995) and postnatal exposure 
to maternal depression has negative effects on offspring mental health (Essex et al., 
2011; Goodman et al., 2011).  It is postulated that maternal depression exerts its 
adverse influence through impaired mother-infant bonding (Bureau et al., 2009; 
Gunnar and Vazquez, 2006; Milan et al., 2009).  
In rodent dams, chronic social stress (CSS, daily exposure to a novel male 
intruder) can be used as an ethologically relevant, transgenerational model of the 
role of stress in the etiology of depression and anxiety in mothers and their 
offspring (Babb et al., 2014; Carini et al., 2013; Carini and Nephew, 2013; 
Murgatroyd and Nephew, 2013; Nephew and Bridges, 2011)(see figure 1).  Exposure 
of F0 lactating dams to CSS as a model for postpartum depression and anxiety 
possesses construct and face validity and depresses maternal care and increases 
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anxiety (Carini et al., 2013; Nephew and Bridges, 2011).  For the young F1 offspring 
of stressed F0 dams, CSS is a robust early chronic social stress (ECSS) which 
includes exposure to both the depressed maternal care from their F0 mothers and 
the conflict between the F0 dam and the male intruders.  Similar to observations in 
human mothers exposed to high levels of early life stress (Goodman, 2007), the 
maternal care displayed by F1 dams towards their F2 offspring is also depressed 
(Carini and Nephew, 2013; Murgatroyd and Nephew, 2013).  Furthermore, the social 
behavior of both male and female F2 offspring (exposed to depressed maternal care 
from their F1 mothers) is impaired (Babb et al., 2014).  Since maternal depression 
can often be predicted from an exposure to early life stress, the CSS F1 and F2 
generations represent relevant models to study the role of ECSS in postpartum 
depression and anxiety and the adverse effects of these disorders on offspring. 
Peripheral and central endocrine studies of the CSS model reveal substantial 
changes in the behaviorally relevant hormones oxytocin (OXT), vasopressin (AVP), 
prolactin (PRL), estradiol, and corticosterone (Carini and Nephew, 2013; Murgatroyd 
and Nephew, 2013).  In the brain, OXT, AVP, and PRL gene expression are altered in 
the hypothalamus of ECSS exposed dams (Murgatroyd and Nephew, 2013).  OXT, 
AVP, and PRL are primary mediators of maternal care and have been implicated in 
the etiology and symptomology of stress related affective disorders (Faron-Górecka 
et al., 2014; Insel and Young, 2001; Mann and Bridges, 2001; Nephew, 2012; Rilling 
and Young, 2014; Zamorano et al., 2014).   Furthermore, OXT is a key mediator of 
the reciprocal nature of the mother-infant bond (Carter, 2003; Feldman et al., 2011; 
Feldman et al., 2007; Henriques et al., 2014; MacKinnon et al., 2014; Mogi et al., 
2011).  The current study investigated additional neural targets that may be 
4
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
involved in the adverse effects of ECSS on the F1 generation and represent novel 
preventative or treatment targets.
The maladaptive impacts of early life stress on mental health are mediated in 
part through changes the hypothalamic–pituitary–adrenal (HPA) axis (Gunnar and 
Vazquez, 2006), although there is growing support for the involvement of multiple 
interacting brain regions and neuroendocrine factors (Lucassen et al., 2014).  There 
is strong evidence that early life stress has persistent effects on the regulation of 
the HPA axis through altered gene expression in the brain which involves changes in 
glucocorticoid receptors (GR) (Liu, 1997; Lupien et al., 2009; McGowan et al., 2009; 
Suderman et al., 2012) as well as more recent data on mineralocorticoid receptors 
(MR) (Baes et al., 2014; Juruena et al., 2013; Klok et al., 2011a; Young et al., 2003). 
It has been suggested that MR receptor activity is increased in patients with 
depression compared to controls, and a systematic review of the role of GR and MR 
in early life stress related depression concludes that the effects of stress on the 
GR/MR ratio may be a key etiological factor in depression, although there are few 
clinical studies that have investigated this role (Von Werne Baes et al., 2012).  Given 
the previously reported HPA changes in the ECSS exposed F1 dams, it was 
postulated that changes in both MR and GR may mediate these effects.
Recent studies suggest that ghrelin, an orexigenic hormone, may be a 
primary mediator of the adverse effects of stress on behavior (Ishitobi et al., 2012; 
Lutter et al., 2008).  Although ghrelin is produced in the stomach, it crosses the 
blood brain barrier (Banks et al., 2002) and ghrelin receptors (GHR) have been 
found in several brain regions, including the paraventricular nucleus (PVN), 
amygdala, and ventral tegmental area (VTA) (Alvarez-Crespo et al., 2012; Perello et 
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al., 2012).  A Leu72Met polymorphism in the ghrelin gene coding region associates 
with depression (Nakashima et al., 2008), and elevated ghrelin levels have been 
found in patients with treatment-resistant depression (Ishitobi et al., 2012), 
suggesting that ghrelin may be a useful indicator of treatment efficacy.  In addition, 
the orexin system, including the expression of orexin and its receptors (Ox1R and 
Ox2R) has been implicated in the expression of both maternal care (D'Anna and 
Gammie, 2006) and depressive behavior and pathophysiology (Arendt et al., 2013; 
Nollet and Leman, 2013).  The clinical and rodent studies indicate that ghrelin and 
orexin may mediate the depressed maternal care in dams exposed to ECSS.
 The brain-derived neurotrophic factor (BDNF) pathway, including extracellular 
signal regulated kinase (ERK) signaling, is another mechanistic target for depression 
research.  In a rat model of infant maltreatment, decreased BDNF levels were found 
to be programmed through an epigenetic mechanism (Roth et al., 2009).  In mice, 
the inhibition of ERK signaling in hippocampus induces depression-like behavior and 
blocks the behavioral effects of antidepressants (Duman et al., 2007; Schmidt and 
Duman, 2007).  Adult rodent exposure to exogenous corticosterone affects phospho-
ERK1/2 levels in the dentate gyrus, and these effects are sensitive to antidepressant 
treatment (Gourley et al., 2008).  Long-term changes in the BDNF pathway are 
associated with childhood adversity and adult depression symptoms (Aguilera et al., 
2009; Gatt et al., 2009).  Mitogen-activated protein kinase phosphatase-1 (MKP-1) 
expression is increased in the postmortem hippocampus of patients with major 
depression compared to healthy controls, and increasing MKP-1 activity in rodent 
models induces depressive behaviors (Duric et al., 2010) and is further regulated by 
BDNF (Jeanneteau et al., 2010).  In the transgenerational CSS model, we propose 
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that ECSS-induced decreases in the BDNF pathway in a nucleus involved in the 
processing of rewarding stimuli, the nucleus accumbens, may mediate decreased 
maternal care and increased anxiety.
The objective of the current study was to augment the previous investigation 
of the endocrine and behavioral effects of ECSS in the F1 generation of CSS model 
of depression and anxiety (Carini and Nephew, 2013) with the addition of 
neuroendocrine analyses of vasopressin, oxytocin, prolactin, ghrelin, orexin, 
corticosteroid receptors, and ERK pathways.  These targets are both translationally 
and clinically relevant.  This broad, yet targeted, approach was taken because 
complex behaviors including maternal care are dependent upon multiple interacting 
brain regions, and ECSS may interact with each of these structures in distinct, 
meaningful ways.  ECSS-induced changes in peripheral estrogen, PRL, 
corticosterone, maternal behavior, and lactation in the F1 dams in this study have 
been previously reported (Carini and Nephew, 2013).  It is hypothesized that AVP, 
OXT, PRL, orexin and BDNF related gene expression and/or protein levels will be 
down regulated in key brain regions in ECSS F1 dams, ghrelin receptors, GR and MR 
will be up-regulated, and these changes will be associated with impairedaltered 
maternal behavior.
METHODS
Animals
Animals in this study were maintained in accordance with the guidelines of 
the Committee of the Care and Use of Laboratory Animals Resources, National 
Research Council, and the research protocol was approved by the Tufts Institutional 
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Animal Care and Use Committee. “CSS dams” refers to the adult females exposed to 
CSS during lactation (F0), and “ECSS dams” refers to the adult female offspring of 
the CSS dams (F1); the focus of the present study.  All the neuroendocrine data and 
behavioral correlations are from ECSS dams (fig. 1).  
CSS model: creation of F0 dams
Dams (Charles River, Wilmington, MA) mated at Tufts University were 
subjected to the CSS protocol (previously described  by Nephew and Bridges, 2011) 
consisting of placing a similarly sized (220–300 g) novel male intruder into a 
lactating female's home cage for 1h from days 2 to 16 of lactation.  Control dams 
were not exposed to the CSS protocol, and were only tested for maternal care and 
maternal aggression between 0800 and 1200 on days 2, 9, and 16 of lactation (both 
control and CSS dams were tested for maternal care and maternal aggression on 
these days).  The F1 pups were left in the cage during the intruder presentation and 
the F1 CSS pups were exposed to depressed maternal care from their F0 mothers 
and the daily conflict between the mother and the male intruder (Nephew and 
Bridges, 2011).  The rationale for the weekly testing was to avoid introducing 
potential confounds involved with an excessive amount of dam/pup separations into 
the model.
ECSS: creation of F1 females
The control and ECSS F1 females of the current study were the offspring of 
the F0 control and CSS dams; the differences between the treatments of the control 
and ECSS F1 females were limited to the exposure of the ECSS F1 females to 
depressed maternal care and daily conflict between their F0 mothers and the male 
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intruders during age 2 to 16 days.  The F1 control and ECSS animals were treated 
identically after the age of 16 days.  After weaning all F1 pups on day 23, the female 
F1 offspring from the twelve F0 control and twelve CSS dams were housed in groups 
of four until 70 days of age when two from each litter were mated with 6 proven 
breeder males in groups of 12 (18 F1 females for both the control and ECSS groups). 
Initial samples sizes for the F1 dams were 14, but 2 control dams were removed 
from the study due to small litter sizes (5 and 6), resulting in n’s of 12 for the 
control, and 14 for the F1 ECSS group.  Total F2 pup number and litter weights were 
recorded on the day of parturition, and litters were then culled to five females and 
five males.  There were no group differences in the dam weights or number or 
weights of pups at birth and across lactation (Carini and Nephew, 2013).   Total 
maternal care was defined as the cumulative duration of pup grooming and nursing, 
and maternal anxiety was defined as the combined duration of self grooming, 
nesting, and non-maternal locomotion during a 30 minute maternal care 
observation on days 2, 9, and 16 between 0800 and 1200, the same testing 
protocol used with F0 maternal care testing.  We have previously reported 
depressed maternal care and/or elevated maternal anxiety in the current ECSS 
dams throughout lactation, with the most substantial effects on day 2 of lactation 
and an overall decrease in total maternal care over all three days of testing in the 
F1 CSS group compared to controls (Carini and Nephew, 2013).  The decrease in 
maternal care was due to significant decreases in the durations of both pup 
grooming and nursing.  While ECSS caused an overall decrease in maternal care 
throughout lactation (days 2, 9, and 16), the greatest effects on both maternal care 
and maternal anxiety were during early lactation on day 2 (Carini and Nephew, 
2013), a critical period for the effects of maternal care on offspring gene expression 
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and development (Champagne et al., 2003; Peña et al., 2013).  All F1 dams were 
euthanized on day 23 of lactation and the brains were extracted and stored at -80C. 
The final sample sizes at the end of lactation were 12 F1 control dams and 14 ECSS 
dams.
RNA expression analyses
Total RNA and DNA were simultaneously extracted from paraventricular 
nucleus (PVN), supraoptic nucleus (SON), medial amygdala (MeA), and central 
amygdala (CeA) brain punches (Bettscheider et al., 2011) and reverse transcription 
(RT) reactions (Bioline) were performed on 200 ng RNA using random primers to 
analyze transcript levels.  Quantitative PCR (qPCR) was performed on a StepOne 
Plus (Applied Biosystems) using Sensi Fast SYBR Green (Bioline).  Primer sequences 
and conditions for qPCR reactions are listed in Table 1.  Expression levels for OXT, 
OXT receptor (OXT R), AVP, AVP V1a receptor (AVPR), the long form of the PRL 
receptor (PRL R), GR (Nr3c1), MR (Nr3c2), Orx1r, Orx2r, Orexin A, and Ghrelin R 
were normalized against three combined housekeeping genes, -β actin, 
hypoxanthine phosphoribosyltransferase (Hprt) and glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh).
Immunoblotting
Protein levels from brain punches of the NAc were analyzed as described 
previously (Krishnan et al., 2007b).  Briefly, samples were homogenized by light 
sonication in RIPA buffer containing protease and phosphatase inhibitors.  Proteins 
were separated on 4-15% polyacrylamide gradient gels (Criterion System, BioRad), 
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and analyzed by western blotting with the antibodies indicated.  Quantification of 
bands was analyzed by normalizing to corresponding beta-tubulin levels, and 
phospho-ERK was normalized to total ERK (Image J).  Primary antibodies used were 
against AKT (Cell Signaling 4691; 1:1000), BDNF (Santa Cruz SC-546, 1:500), beta-
tubulin (Cell Signaling 2128, 1:1000), ERK1/2 (p44/42 MAPK, Cell Signaling 4695, 
1:1000), phospho-ERK1/2 (p44/42 MAPK, Cell Signaling 4370, 1:2000), FosB (Santa 
Cruz SC-48, 1:500).  
Statistics
Relative mRNA expression and protein levels were compared with individual 
ANOVA for each brain region.  Where non-significant trends in the ANOVA results 
were present, these tests were followed with 1-tailed t-tests with Benjamini and 
Hochberg multiple comparison correction (Benjamini and Hochberg, 1995) if 
justified by previous studies of the CSS model (OXT and GR).  We have previously 
reported decreased OXT in the MeA (Murgatroyd and Nephew, 2013), and have 
observed a significant increase in hypothalamic GR expression in the F0 dams which 
is associated with decreased methylation at the CpG2 promoter region (data 
submitted for publication).   Pearson correlations were used to test for significant 
gene-behavior associations in restricted data sets (total maternal care and total 
maternal anxiety on lactation day 2 with the 12 significant differences in gene 
expression/protein levels (figs. 2-5) in the control and ECSS groups, and both groups 
combined).    All graphical results are presented as mean + SEM, and the level of 
statistical significance was p < 0.05.
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RESULTS
Gene and Protein Expression
In the PVN, exposure to ECSS was associated with decreased AVP mRNA 
expression among F1 dams (F1,25= 4.1, p=0.05, Fig. 1A), and increased Ghrelin R 
(F1,25= 5.8, p<0.05, Fig. 1B) and MR (F1,25= 12.4, p<0.01, Fig. 1C) mRNA.  In addition, 
the GR/MR mRNA ratio was decreased in the ECSS dams (F1,25= 8.3, p<0.01, Fig. 
1D).  In the SON, GR expression was increased in ECSS dams (F1,25= 3.0, p=0.1, 
t<0.05 Fig. 2A), and Orexin A (F1,25= 4.7, p<0.05, Fig. 2B), Orx1R (F1,25= 4.9, p<0.05, 
Fig. 2C) and Orx2R (F1,25= 6.4, p<0.05 Fig. 2D) were all decreased in stressed dams. 
In the CeA, ECSS was associated with increased OXTR  (F1,25= 6.1, p<0.05, Fig. 3A) 
and AVP (F1,25= 5.7, p<0.05, Fig. 3B) mRNA.  In the MeA, expression of both OXT 
(F1,25= 3.7, p=0.07, t=0.03, Fig. 3CD) and AVP (F1,25= 5.0, p<0.05, Fig. 3D) were 
decreased.  Investigation of BDNF and ERK protein levels in the NAc revealed 
decreased total ERK protein (F1,25= 13.7, p<0.01, Fig. 4A) but an elevated 
phosphorylated ERK/total ERK ratio (F1,25= 7.7, p<0.01, Fig. 4B), with a trend for 
elevated pERK relative to beta-tubulin.
Gene-Behavior Correlations (Table 2)
When correlating gene expression levels with behavioral measures, AVP in 
the CeA was negatively correlated with maternal anxiety in the ECSS dams; in 
contrast, AVP in the MeA was positively correlated with maternal anxiety.  AVP in the 
PVN was positively correlated with maternal care and negatively correlated with 
maternal anxiety in both groups combined.  ERK protein levels in the NAc were 
positively correlated with maternal care and negatively correlated with maternal 
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anxiety in both groups combined.  Ghrelin R expression in the PVN was positively 
correlated with maternal anxiety in both groups combined.  GR in the SON was 
negatively correlated with maternal care in control dams, and negatively correlated 
with maternal anxiety in stressed dams.  MR in the PVN was positively correlated 
with maternal anxiety in both groups combined.  Orexin A and Orx1R in the SON 
were negatively correlated with maternal care in the control dams, and Orx1R and 
Orx2R were negatively correlated with maternal anxiety in the CSS group or both 
groups combined.  Orx2R was also positively correlated with maternal care in the 
SON.
DISCUSSION
The present study reports novel changes in gene expression and ERK protein 
levels in the brains of rat dams exposed to chronic ECSS.  Substantial changes in 
vasopressin, oxytocin, orexin, ghrelin, glucocorticoid and mineralocorticoid 
receptors, and the BDNF pathway underscore related work on the adverse long-term 
effects of early life stress on neural activity and plasticity, maternal behavior, 
responses to stress, and depression and anxiety-related behavior.  Correlations 
between gene targets and both groups combined (as found with AVP, ERK, GHR, MR, 
and Orx2R) indicate that those gene targets mediate the behavioral difference 
between the two groups.  Correlations with only the control or ECSS groups indicate 
that the changes in those genes mediate behavioral variation within the control or 
ECSS group, but that the changes are not directly associated with the between 
group differences or variation in the other group.  The gene and protein expression 
and robust behavioral correlations support increased focus on vasopressin, ghrelin, 
orexin and changes in both glucocorticoid and mineralocorticoid receptors in both 
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animal and clinical studies of the adverse effects of early life stress, especially those 
focusing on depression and anxiety in mothers and transgenerational effects on 
offspring (Apter-Levy et al., 2013; Feldman et al., 2009; Whelan et al., 2015).  
Several studies have confirmed the importance of AVP in the display of 
maternal care (Bosch and Neumann, 2008; Bosch and Neumann, 2012; Nephew and 
Murgatroyd, 2013; Nephew, 2012), and the decrease in AVP in the PVN reported 
here may mediate the previously documented depressed maternal care and 
increased anxiety in these F1 dams (Carini and Nephew, 2013), as supported by the 
positive correlations between maternal care  and AVP and negative correlations 
between maternal anxiety and AVP.  Neural AVP promotes ongoing maternal care 
(Bosch and Neumann, 2008; Nephew and Bridges, 2008b), and the central blockage 
of AVP V1a receptors at parturition interferes with maternal memory (Nephew and 
Bridges, 2008a).  In CSS exposed F0 dams, exogenous chronic icv AVP treatment 
ameliorates some of the negative effects of social stress on maternal care (Coverdill 
et al., 2012).  Early life exposure of the F1 dams to depressed maternal care and 
social conflict may decrease PVN AVP activity through a developmental, possibly 
epigenetic, mechanism which mediates the impaired maternal care of F1 animals 
towards their F2 pups (Murgatroyd et al., 2009).  It is also possible that this change 
in hypothalamic AVP may mediate the depressed milk intake in the F1 dams, as 
both maternal care and lactation are decreased in these dams (Carini and Nephew, 
2013), similar to comorbid depression and lactational difficulties in humans (Stuebe 
et al., 2013; Stuebe et al., 2012).  In addition to the change in PVN AVP, the 
expression of this neuropeptide was also altered in the CeA and MeA, and these 
changes were associated with maternal anxiety on day 2.  While the specific 
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functions of the reported changes in amygdalar AVP require further study, it is clear 
that exposure to ECSS disrupts AVP activity in the brain, and underscores the 
complex relationship between AVP, maternal behavior, and anxiety (Bosch, 2011; 
Bosch and Neumann, 2008; Kessler et al., 2011).  It is possible that changes in 
amygdalar AVP were compensatory responses to the increase in maternal anxiety in 
the ECSS dams, and this hypothesis is supported by the observed changes in 
expression and correlations between AVP and anxiety.  Decreased AVP in the MeA is 
correlated with maternal anxiety and increased AVP in the CeA is negatively 
correlated with maternal anxiety.  
The other significant change in gene expression in the CeA of stressed dams 
was an increase in OXTR.  Similar to the increase in AVP expression, this change 
may have been part of compensatory mechanism in response to low levels of OXT in 
the amygdala and/or deficient maternal care.  These data add to recent studies 
implicating disruption in peripheral and central OXT in pathological differences in 
depressed mothers (Kim et al., 2014) as well as the growing literature on the role of 
central OXT in the effects of early social environment on the development of social 
behavior (Alves et al., 2015)in typical maternal responsiveness and care.  The lack 
of significant correlations between the neural changes and maternal behavior in the 
present study may indicate that the effects of ECSS on maternal care and maternal 
anxiety may be mediated by a complex array of factors and that future rodent and 
human studies of oxytocin and maternal care should include additional factors 
associated with OXT.  Oxytocin’s beneficial or adverse effects may be mediated 
through changes in ERK mediated plasticity, AVP, corticosteroid receptors, ghrelin, 
and/or orexin.  Taken together, the hypothalamic and amygdalar AVP and OXT 
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findings support the specific importance of these neuropeptides in the regulation of 
both maternal care and anxiety in animal models of early life stress-associated 
disorders.
Exposure to ECSS also increases ghrelin R expression in the PVN and this 
change was correlated with anxiety in both groups combined, similar to reports in 
male rats (Carlini et al., 2002; Carlini et al., 2004).  Chronic icv ghrelin treatment 
increases depression and anxiety related behaviors in male rats (Hansson et al., 
2011), and the PVN appears to be an area particularly sensitive to the anxiogenic 
effects of ghrelin (Currie et al., 2012), possibly mediated through changes in AVP 
(Poretti et al., 2015).  Serum ghrelin levels in humans are elevated in patients with 
major depression, and responders to treatments for depression and panic disorder 
have lower ghrelin levels than non-responders (Ishitobi et al., 2012).  On the other 
hand, ghrelin is reported to mediate resilience to chronic social stress in male mice 
(Lutter et al., 2008).  While more data on developmental changes in peripheral and 
central ghrelin and ghrelin receptor levels are needed, the current data support the 
hypothesis that increased ghrelin activity increases maternal anxiety associated 
behaviors in thehis model of ECSS model.
Another HPA-related change in the PVN was an increase in PVN MR 
expression.  ECSS increased MR expression in the PVN and lowered the GR/MR ratio, 
and MR was correlated with maternal anxiety, a maladaptive change in the ECSS 
group.  There is growing evidence of a role for MR activity in the effects of early life 
stress on HPA development and activity (Baes et al., 2014; Juruena, 2013; Qi et al., 
2013; Young et al., 2003).  MR haplotypes mediate the cumulative effects of stress 
on depression symptoms in females (Klok et al., 2011b), and region dependent 
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differences in neural MR gene expression have been reported in humans (Klok et al., 
2011a). The present MR data indicate that social stress exposure exerts its long 
term effects through changes in hypothalamic MR activity, and the correlation 
between MR in the PVN and anxiety in both groups combined indicates that MR in 
this region mediates the effect of ECSS on maternal anxiety.  Previous studies of the 
CSS model support the hypothesis that the reported modulation in the GR/MR ratio 
is disruptive to the HPA axis.  Since it has been documented that F1 animals have 
elevated basal corticosterone at both the adult and dam stages (Carini and Nephew, 
2013), it is postulated that the increase in PVN MR is in response to increased 
corticosterone levels and/or reduced GR activity.   The present MR data support 
growing interest in central MR function as a novel treatment target for stress 
associated psychiatric disorders (Harris et al., 2013; Medina et al., 2013; Otte et al., 
2015; Von Werne Baes et al., 2012).  
The orexin system has been implicated in the pathophysiology of depression 
(Nollet and Leman, 2013) due to its involvement in the mediation of multiple 
systems, including arousal, sleep/wake cycles, feeding, stress responses, and 
reward (Di Sebastiano and Coolen, 2012; Li et al., 2014) and depression associated 
hypothalamic changes in rodent models (Nocjar et al., 2012).  Studies in mice have 
implicated central orexin activity in the control of maternal care, a robust reward 
mediated behavior, and maternal aggression (D'Anna and Gammie, 2006).  Changes 
in orexin are also associated with exposure to neonatal maternal deprivation (a 
robust form of early life stress), and exercise (Feng et al., 2007; James et al., 2014), 
supporting the hypothesis that orexin may mediate the reported transgenerational 
effects of ECSS on F1 and F2 offspring.  We report hypothalamic changes in orexin 
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activity and depressed maternal care and increased anxiety in dams exposed to 
ECSS, similar to our previous finding of altered Orx1R expression in the stressed F0 
mothers of these F1 animals (Murgatroyd et al., 2015)(Murgatroyd et al. submitted). 
There was an overall decrease in orexin A activity in the SON, and the associations 
between Orx2R and maternal care and anxiety in both groups indicates that the 
ECSS induced changes in behavior are most likely to be mediated by Orx2R, with 
orexin A and Orx1R being involved in variation in typical maternal care and the 
individual anxiety response to early life stress.  The importance of the orexin 
receptors in behavioral despair has been previously documented in studies of knock 
out mice, where an Orx2R knockout displayed increased behavioral despair, with 
opposite effects in a Orx1R knockout (Scott et al., 2011).  Similarly, we report a 
positive correlation between Orx2R and maternal care, and negative correlation 
between Orx1R and maternal care.  Our data also specifically support recent work 
reporting decreased hypothalamic orexin A activity in rats exposed to early life 
maternal separation stress over days 2-14 of lactation (James et al., 2014), another 
ethologically relevant social stress.
Results from the total ERK and pERK analyses reveal that ERK activity was 
altered in the ECSS dams compared to controls.  While the literature on BDNF and 
depression and anxiety disorders is mixed, the current results add support to the 
hypothesis that early life stress alters mechanisms of neuronal plasticity.  Despite a 
decrease in total ERK in the NAc, there was a significant increase in pERK relative to 
tERK and a trend for increased pERK relative to control protein, which is indicative of 
greater functional ERK activity.  Although we did not see significant effects of ECSS 
on BDNF levels, it is possible that we missed a significant change in BDNF during or 
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shortly after the ECSS exposure which may have had a lasting organizational or 
epigenetic effects on downstream targets throughout the CNS.  The decrease in 
total ERK may be indicative of attenuated synaptic plasticity and associated 
behavioral changes (Marsden, 2013).  Similar to the current data, total ERK1/2 
protein levels are decreased in the brains of suicide victims (Dwivedi et al., 2001), 
and it is postulated that this decrease in the stressed dams is an indicator of 
depressed maternal care.  In terms of pERK, social defeat, another potent social 
stressor commonly used in males, increases pERK in the VTA (Iniguez et al., 2010) 
and the NAc, and inhibition of ERK signaling in the NAc blocks the effects of social 
defeat on depression-like behavior in males (Krishnan et al., 2007a).  The relative 
increase in pERK may mediate the effects of ECSS on maternal care and anxiety. 
The strength of the associations between ERK levels and maternal care and anxiety 
could indicate that changes in the expression of other behaviorally significant neural 
systems (AVP, OXT, orexin, corticosterone receptors) are developmentally mediated 
by alterations in neuroplasticity in the NAc.  Given the importance of plasticity in the 
maternal brain (Galea et al., 2014; Kim et al., 2010; Kinsley and Lambert, 2008), 
changes in ERK may be especially relevant to peripartum depression and anxiety. 
While the current study is limited to the NAc, it is possible that ERK-related gene 
expression is altered in several other regions, such as the hypothalamus and 
amygdala.
The main limitation of the study is the 20 day interval between the behavioral 
data and the tissue sampling for gene expression and protein levels.  Considering 
that the exposure to ECSS was during the first two weeks of life of the dams and 
that the control and ECSS dams were treated identically during the time when they 
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were caring for their own pups, the focus of the present study was on the effects of 
ECSS on gene expression and behavior that would be expected to be present 
throughout lactation.  While tissue sampling at different time points during lactation 
would be a valuable component to future studies, prior investigations report that 
OXT and AVP mRNA and their respective receptor mRNA levels (Nephew et al., 
2009) and OXT receptor and AVP V1a receptor binding (Caughey et al., 2011) are 
relatively consistent across lactation in the PVN, SON, MeA, and CeA of primiparous 
animals.  Furthermore, we focused on targets that are associated with maternal care 
and/or depression/anxiety both during and not during episodes of impaired maternal 
care and depression/anxiety, such as plasma oxytocin levels during pregnancy and 
postpartum depression (Skrundz et al., 2011) and the relationship between early life 
stress, GR/MR, and depression (Von Werne Baes et al., 2012).  Taken together, the 
design of the CSS model and the focal endocrine targets support the hypothesis 
that the correlations between behavior during early lactation and gene expression 
at the end of lactation are relevant for the purpose of identifying factors that may 
mediate both typical maternal care and the adverse effects of ECSS on maternal 
care, depression, and anxiety.
With growing evidence for stress associated transgenerational mechanisms 
and mediating roles of early life stress and/or parental behavior in several 
psychiatric disorders, the current results on long-term alterations in gene 
expression, protein levels, and robust behavioral associations support continued or 
additional translational investigation of the roles of vasopressin, oxytocin, orexin, 
ghrelin, corticosteroid receptors, and neuroplasticity in stress related disorders in 
mothers and their offspring.  Additional investigations of etiological plasticity in the 
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hypothalamus and amygdala, as well as behavioral gene expression in the nucleus 
accumbensNAc, are warranted.  A combination of targets that already have clinically 
available treatments (often developed for non-psychiatric conditions) and the 
preventative potential for future generations (Babb et al., 2015) suggest that 
research in these areas may be highly productive in the development of new 
treatments and preventative measures.
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Figure 1  Diagram of the Chronic Social Stress paradigm.  The current study 
involved the dams from the F1 generation.  Testing on postpartum days 2, 9, and 16 
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included maternal care and maternal aggression.  Brain and blood samples from the 
F1 dams were obtained on postpartum day 23 when the F2 pups were weaned. 
These samples were analyzed for the expression of oxytocin, oxytocin receptor, 
vasopression, vasopression V1a receptor, prolactin receptor, glucocorticoid and 
mineralocorticoid receptors, orexin A, orexin receptors 1 and 2, ghrelin receptor, 
and protein levels of BDNF, ERK1/2, and phospho-ERK1/2.
Figure 2 Mean + SEM relative mRNA expression levels of AVP (A),  Ghrelin R (B), 
MR (C), and GR/MR ratio (D) in the PVN of control (n=12) and ECSS (stress) (n=14) 
dams.  * Indicates a significant effect of CSS, p<0.05
Figure 3 Mean + SEM relative mRNA expression levels of GR (A), Orexin (B), Orx1R 
(C), and Orx2R (D) in the SON of control (n=12) and ECSS (stress) (n=14) dams.  * 
Indicates a significant effect of CSS, p<0.05
Figure 4 Mean + SEM relative mRNA expression levels of OXTR (A) and AVP (B) in 
the CeA and of OXT (C), and AVP (D) in the MeA of control (n=12) and ECSS (stress) 
(n=14) dams.  * Indicates a significant effect of CSS, p<0.05
Figure 5 Mean + SEM relative protein levels (normalized to beta-tubulin) of total 
ERK (A) and phospho-ERK/total ERK ratio (B) in the NAc of control (n=12) and ECSS 
(stress) (n=14) dams.  * Indicates a significant effect of CSS, p<0.05
30
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
31
894
895
